Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non–Small Cell Lung Cancer
2018 · JAMA Oncology · 925 citations
https://doi.org/10.1001/jamaoncol.2017.4771
É
Édouard Auclin
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
265
Papers
5.6K
Citations
31
h-index
77
i10-index
Édouard Auclin is an academic researcher from Inserm. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Lung Cancer Treatments and Mutations & Cancer Genomics and Diagnostics. The author has an h-index of 31, co-authored 226 publications.
ORCID: 0000-0001-7039-4840Papers by this author
worksOutcomes in elderly patients admitted to the intensive care unit with solid tumors
2017 · Annals of Intensive Care · 68 citations
https://doi.org/10.1186/s13613-017-0250-0
Association of cabozantinib pharmacokinetics, progression and toxicity in metastatic renal cell carcinoma patients: results from a pharmacokinetics/pharmacodynamics study
2021 · ESMO Open · 31 citations
https://doi.org/10.1016/j.esmoop.2021.100312
Association of the prognostic model iSEND with PD-1/L1 monotherapy outcome in non-small-cell lung cancer
2019 · British Journal of Cancer · 28 citations
https://doi.org/10.1038/s41416-019-0643-y
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trial
2019 · British Journal of Cancer · 21 citations
https://doi.org/10.1038/s41416-019-0521-7
Efficacy and safety of the combination of encorafenib/cetuximab with or without binimetinib in patients with BRAF V600E-mutated metastatic colorectal cancer: an AGEO real-world multicenter study
2024 · ESMO Open · 15 citations
https://doi.org/10.1016/j.esmoop.2024.103696
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat